Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transcription”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03132155
What this trial is testing

QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma

Who this might be right for
Clear Cell Sarcoma
NantPharma, LLC 8
Post-approval studies (Phase 4)Ended earlyNCT01606709
What this trial is testing

Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation

Who this might be right for
Endometrial ReceptivityOvarian Hyperstimulation Syndrome
UConn Health 7
Testing effectiveness (Phase 2)Study completedNCT01872546
What this trial is testing

Skin Transcriptional Profiles In Psoriatic Patients Under Adalimumab Biotherapy

Who this might be right for
Chronic Plaque Psoriasis
Poitiers University Hospital 18
Testing effectiveness (Phase 2)Study completedNCT00557609
What this trial is testing

Phase 2 Study in Patients With MiT Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Alveolar Soft Part Sarcoma (ASPS)Clear Cell Sarcoma (CCS)
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 47
Not applicableStudy completedNCT01505699
What this trial is testing

Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group 186
Early research (Phase 1)Study completedNCT03195699
What this trial is testing

Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers

Who this might be right for
Breast CancerHead and Neck Squamous Cell CarcinomaNon Small Cell Lung Cancer+5 more
Tvardi Therapeutics, Incorporated 64
Testing effectiveness (Phase 2)Looking for participantsNCT06228066
What this trial is testing

Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)

Who this might be right for
Small Cell Carcinoma of the BladderHigh Grade Neuroendocrine Tumors of the Urinary Tract
National Cancer Institute (NCI) 45
Post-approval studies (Phase 4)UnknownNCT01301794
What this trial is testing

Lovaza Mechanisms of Action

Who this might be right for
Moderate Hypertriglyceridemia.
Brigham and Women's Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT00911248
What this trial is testing

PTC299 for Treatment of Neurofibromatosis Type 2

Who this might be right for
Neurofibromatosis 2
PTC Therapeutics 11
Not applicableLooking for participantsNCT03769415
What this trial is testing

Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 500
Testing effectiveness (Phase 2)Study completedNCT00404326
What this trial is testing

Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer

Who this might be right for
Cervical Cancer
National Institute of Cancerología 18
Not applicableEnded earlyNCT00512369
What this trial is testing

Effects of PA-1 Transcriptional Regulation on Monocyte Function

Who this might be right for
Atherosclerosis
Vanderbilt University 125
Testing effectiveness (Phase 2)Ended earlyNCT03153982
What this trial is testing

Ruxolitinib in Operable Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma
University of California, San Francisco 16
Post-approval studies (Phase 4)Study completedNCT04157010
What this trial is testing

Tocilizumab REMission in Early RA

Who this might be right for
Rheumatoid Arthritis
University of Leeds 20
Not applicableStudy completedNCT00897650
What this trial is testing

Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer

Who this might be right for
Lung Cancer
Vanderbilt-Ingram Cancer Center 204
Testing effectiveness (Phase 2)Study completedNCT01666418
What this trial is testing

Pilot Study Investigating the Metabolic Activity and Transcriptional Profiling in Vivo in Tumor Biopsies in Melanoma Patients During Treatment With Pazopanib Alone and in Combination With Paclitaxel

Who this might be right for
Melanoma
University of Zurich 19
Testing effectiveness (Phase 2)Looking for participantsNCT06566079
What this trial is testing

Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

Who this might be right for
Malignant MesotheliomaMetastatic Malignant Solid TumorAdvanced Solid Tumor
InSilico Medicine Hong Kong Limited 160
Testing effectiveness (Phase 2)Looking for participantsNCT04683315
What this trial is testing

PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples

Who this might be right for
Pancreatic Cancer
Medical College of Wisconsin 84
Not applicableUnknownNCT01228786
What this trial is testing

Regulation of Vitamin D Receptor (VDR),Calcium Sensing Receptor (CaSR), Cyclin D1,Ki67 and Proliferating Cell Nuclear Antigen (PCNA) in Primary Hyperparathyroidism

Who this might be right for
Primary Hyperparathyroidism (PHPT)
Post Graduate Institute of Medical Education and Research, Chandigarh 50
Not applicableStudy completedNCT04570306
What this trial is testing

Transcriptional and Immune Parameters of Response to Belimumab

Who this might be right for
Systemic Lupus Erythematosus
Biomedical Research Foundation, Academy of Athens 85
Next Page